|
Insider Trading: PHARMION CORP
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PHARMION CORP in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of PHARMION CORP since year 2005. Table 2 shows the detailed insider transactions of PHARMION CORP since 2005.
The reporting company's ticker symbol is PHRM.
The reporting company's CIK number is 1203866.
The total value of stock buying since 2005 is $21,312,970.
The total value of stock sales is $4,875,940.
The total value of stock exercises is $3,312,240.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at PHARMION CORP (PHRM) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at PHARMION CORP (PHRM) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for PHARMION CORP (PHRM).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-03 | 0 | 0 | 0 | 0 | 132,443 | 2,332,810 |
| 2007-12 | 0 | 0 | 0 | 0 | 7,037 | 450,001 |
| 2007-11 | 0 | 0 | 0 | 0 | 32,813 | 193,268 |
| 2007-09 | 0 | 0 | 0 | 0 | 1,250 | 51,262 |
| 2007-08 | 0 | 0 | 83,840 | 3,445,443 | 60,000 | 284,899 |
| 2006-08 | 1,300 | 22,867 | 0 | 0 | 0 | 0 |
| 2006-06 | 46,300 | 818,416 | 0 | 0 | 0 | 0 |
| 2006-05 | 1,012,000 | 19,332,599 | 0 | 0 | 0 | 0 |
| 2006-03 | 42,813 | 729,248 | 21,666 | 366,113 | 0 | 0 |
| 2006-02 | 1,500 | 23,250 | 0 | 0 | 0 | 0 |
| 2005-12 | 0 | 0 | 7,650 | 141,035 | 0 | 0 |
| 2005-11 | 0 | 0 | 50,000 | 923,349 | 0 | 0 |
| 2005-10 | 22,000 | 386,590 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for PHARMION CORP (PHRM)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-03-07 | Allen Andrew R (Chief Medical Officer, EVP) | Option Exercise | 3,800 | 72.49 | 275,462 |
| 2008-03-07 | Dupont Steven N (EVP and General Counsel) | Option Exercise | 1,650 | 72.49 | 119,608 |
| 2008-03-07 | Cosgrave Michael (EVP, Global Commercial) | Option Exercise | 3,750 | 72.49 | 271,837 |
| 2008-03-07 | Ivers-read Gillian C (EVP, Development Operations) | Option Exercise | 2,100 | 72.49 | 152,229 |
| 2008-03-07 | Mahaffy Patrick J (CEO, President) | Option Exercise | 9,375 | 72.49 | 679,593 |
| 2008-03-07 | Mast Erle T (EVP, CFO) | Option Exercise | 2,625 | 72.49 | 190,286 |
| 2008-03-04 | Mahaffy Patrick J (CEO, President) | Option Exercise | 46,330 | 11.25 | 521,366 |
| 2008-03-03 | Mast Erle T (EVP, CFO) | Option Exercise | 62,500 | 1.60 | 100,000 |
| 2008-03-01 | Allen Andrew R (Chief Medical Officer, EVP) | Option Exercise | 313 | 71.66 | 22,429 |
| 2007-12-06 | Allen Andrew R (Chief Medical Officer, EVP) | Option Exercise | 225 | 63.98 | 14,395 |
| 2007-12-06 | Dupont Steven N (Executive VP, General Counsel) | Option Exercise | 550 | 63.98 | 35,189 |
| 2007-12-06 | Cosgrave Michael (EVP, Global Commercial) | Option Exercise | 1,250 | 63.98 | 79,975 |
| 2007-12-06 | Ivers-read Gillian C (EVP, Development Operations) | Option Exercise | 700 | 63.98 | 44,786 |
| 2007-12-06 | Mahaffy Patrick J (CEO, President) | Option Exercise | 3,125 | 63.98 | 199,937 |
| 2007-12-06 | Mast Erle T (EVP, CFO) | Option Exercise | 875 | 63.98 | 55,982 |
| 2007-12-01 | Allen Andrew R (Chief Medical Officer, EVP) | Option Exercise | 312 | 63.26 | 19,737 |
| 2007-11-08 | Ivers-read Gillian C (EVP, Development Operations) | Option Exercise | 32,813 | 5.89 | 193,268 |
| 2007-09-01 | Allen Andrew R (Chief Medical Officer, EVP) | Option Exercise | 1,250 | 41.01 | 51,262 |
| 2007-08-24 | Ivers-read Gillian C (EVP, Development Operations) | Sale | 23,840 | 38.53 | 918,507 |
| 2007-08-06 | Dupont Steven N (VP, General Counsel) | Sale | 10,000 | 42.69 | 426,936 |
| 2007-08-06 | Dupont Steven N (VP, General Counsel) | Option Exercise | 10,000 | 18.49 | 184,899 |
| 2007-08-06 | Mast Erle T (EVP, CFO) | Sale | 50,000 | 42.00 | 2,100,000 |
| 2007-08-06 | Mast Erle T (EVP, CFO) | Option Exercise | 50,000 | 2.00 | 100,000 |
| 2006-08-06 | Mckinley Edward J (Director) | Purchase | 1,300 | 17.59 | 22,867 |
| 2006-06-09 | Blair James C (Director) | Purchase | 31,600 | 17.71 | 559,636 |
| 2006-06-08 | Mckinley Edward J (Director) | Purchase | 14,700 | 17.60 | 258,780 |
| 2006-05-04 | Blair James C (Director) | Purchase | 285,200 | 19.98 | 5,698,296 |
| 2006-05-03 | Blair James C (Director) | Purchase | 500,000 | 18.64 | 9,320,000 |
| 2006-05-02 | Blair James C (Director) | Purchase | 103,000 | 19.01 | 1,958,030 |
| 2006-05-01 | Mckinley Edward J (Director) | Purchase | 12,000 | 19.06 | 228,719 |
| 2006-05-01 | Blair James C (Director) | Purchase | 111,800 | 19.03 | 2,127,554 |
| 2006-03-03 | Mckinley Edward J (Director) | Purchase | 34,000 | 17.11 | 578,736 |
| 2006-03-03 | Hemberger Judith A (Exec VP and COO) | Sale | 21,666 | 16.90 | 366,113 |
| 2006-03-02 | Mahaffy Patrick J (President and CEO) | Purchase | 5,882 | 17.01 | 100,052 |
| 2006-02-24 | Mast Erle T (Executive VP and CFO) | Purchase | 1,500 | 15.50 | 23,250 |
| 2005-12-13 | Ivers-read Gillian C (Vice President) | Sale | 7,650 | 18.44 | 141,035 |
| 2005-11-01 | Hemberger Judith A (Exec VP and COO) | Sale | 50,000 | 18.47 | 923,349 |
| 2005-10-28 | Mckinley Edward J (Director) | Purchase | 20,000 | 17.57 | 351,420 |
| 2005-10-28 | Mast Erle T (Chief Financial Officer) | Purchase | 2,000 | 17.58 | 35,170 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of PHARMION CORP (symbol PHRM,
CIK number 1203866) see
the Securities and Exchange Commission (SEC) website.
|
|
